Keol-C (Oxygen)

Oxygen delivered by Keol‑C increases the partial pressure of oxygen in the lungs, which enhances diffusion across the alveolar‑capillary membrane into the bloodstream. The rise in arterial oxygen tension improves the amount of oxygen that reaches tissues, supporting cellular metabolism and preventing hypoxic injury.

The dose of Keol‑C is individualized. A prescriber determines the appropriate flow rate, concentration and duration of therapy based on the patient’s oxygen saturation, underlying condition and clinical response. The exact regimen is set by the treating healthcare professional.

Oxygen is generally considered safe for pregnant or breastfeeding patients when clinically indicated, as it does not cross the placenta in harmful amounts. Nevertheless, its use should be limited to situations where the benefits outweigh any potential risks and should be overseen by a qualified medical professional.

To order Keol‑C, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Keol‑C is supplied as a medical‑grade oxygen cylinder, offering high‑purity gas for precise flow‑rate control. Compared with liquid oxygen systems or oxygen concentrators, cylinders provide portability and immediate availability but require proper storage and handling. The choice depends on clinical setting, duration of therapy and infrastructure.

Keol‑C cylinders should be stored at ambient temperature in a well‑ventilated, dry area away from heat sources, open flames and combustible materials. They must be secured upright, protected from physical damage, and handled only by trained personnel using appropriate cylinder‑handling equipment.

Keol‑C is administered by connecting the oxygen cylinder to a regulator and then to a delivery device such as a face mask, nasal cannula or non‑rebreather mask. The prescriber sets the flow rate, and the patient inhales the oxygen directly through the chosen interface.

Serious risks include pulmonary oxygen toxicity, which can cause inflammation and lung injury, and the potential for seizures due to hyperoxia. In neonates, prolonged high‑concentration exposure may lead to retinopathy of prematurity. Additionally, oxygen supports combustion, creating a fire or explosion hazard if proper safety measures are not followed.

Keol‑C should be avoided in patients with known hypersensitivity to oxygen therapy equipment, those with untreated pneumothorax, or individuals at high risk of oxygen‑induced lung injury such as patients receiving high‑dose bleomycin. It should also not be used in environments where flammable gases or vapors are present without appropriate safety controls.